Based on our findings, we conclude that myofibroblast-derived CRC, TNS1, and FERMT2 orchestrate tumour progression by upregulating FN1, which subsequently activates integrin and FAK signaling in cancer cells (Fig. 7g). This evidence concerns the gene FERMT2 and colorectal carcinoma.